Pharmacists in Rumford, RI Accepting Medicare

8 Pharmacists found. Showing 1 - 8

Bethany Ann Carroll, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Newport Ave, Rumford, RI 02916 Phone: 401-434-1333    Fax: 401-435-4569

Neveen A Hanna Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Newport Ave, Rumford, RI 02916 Phone: 401-434-1333    Fax: 401-435-4569

Samantha Clark Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 63 Newport Ave, Rumford, RI 02916 Phone: 401-431-0461

Kevin G Mendonca, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Newport Ave, Rumford, RI 02916 Phone: 401-434-1333

Mr. Robert D. Hamann, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Newport Ave, Rumford, RI 02916 Phone: 401-434-1333

Dr. Ryan James Maslyn, PHAMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 63 Newport Ave, Rumford, RI 02916 Phone: 401-431-0461

Lisa Helgerson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Newport Ave, Rumford, RI 02916 Phone: 401-434-1333

Joseph James Turcotte, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Newport Ave, Rumford, RI 02916 Phone: 401-434-1333

News Archive

Janssen submits XARELTO sNDA with FDA to reduce risk of stent thrombosis in ACS patients

Janssen Research & Development, LLC announced today that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of XARELTO, an oral anticoagulant, to reduce the risk of stent thrombosis in patients with Acute Coronary Syndrome.

Study finds one third of American adults serves as a caregiver

"A new study says almost one out of three adults in the U.S. currently serves as a caregiver," NPR reports. "The time and energy they put into caregiving becomes like an unpaid job. On average, they spend about 19 hours a week providing care, doing everything from bathing and dressing an elderly parent or loved one to balancing a checkbook or doing household chores."

New project to study effect of climate change on society's vulnerability to dengue fever

New research project will study how changes and variations in climate affect a society's vulnerability and risk of mosquito-transmitted diseases, particularly dengue fever, in Southeast Asia.

Uroplasty prices underwritten public offering of common stock

Uroplasty, Inc. announced today that its underwritten public offering of 4 million shares of its common stock was priced at $3.50 per share. Uroplasty has granted the underwriters of the offering an option to purchase up to an additional 600,000 shares of common stock within the next 30 days, solely to cover over-allotments, if any. All of the shares in the offering are being offered by Uroplasty. Uroplasty expects the offering to close on July 27, 2010, subject to customary closing conditions.

Study results do not show benefit of proteomic analysis for detecting diabetic nephropathy

One of the consequences of diabetes mellitus, particularly if accompanied by high blood pressure (hypertension), can be a chronic kidney disease (diabetic nephropathy), which can lead to permanent failure of the kidneys (end-stage renal disease).

Read more Medical News

› Verified 3 days ago